Below you will find information from the register publication of inside information. The information has been provided by the organisation.
- Registration date 09 mar 2006 - 08:03
- Statutory name Crucell N.V.
- Title Crucell and DSM Biologics Announce PER.C6® Licensing Agreement with UMN Pharma
- Comments Dutch biotechnology company Crucell N.V. (Euronext and NASDAQ: CRXL; Swiss Exchange: SW CRX) and allied contract manufacturer DSM Biologics announced today that they have signed a PER.C6® research license agreement with Japanese pharmaceutical company UMN Pharma.
Date last update: 12 August 2020